Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Carvajal, Alfonso ^a   Ortega, Sara ^a   Del Olmo, Lourdes ^a   Vidal, Xavier ^b,c   Aguirre, Carmelo ^d   Ruiz, Borja ^d   Conforti, Anita ^e   Leone, Roberto ^e   López Vázquez, Paula ^f,g   Figueiras, Adolfo ^f,g   Ibáñez, Luisa ^b,c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Fundacion Institut Catala de Farmacologia   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DE GALDAKAO   (Spain)

^e UNIVERSITY OF VERONA   (Italy)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TOLERABILITY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SELF MEDICATION; UPPER GASTROINTESTINAL BLEEDING; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; GASTROINTESTINAL HEMORRHAGE; ITALY; MIDDLE AGED; MULTICENTER STUDY; SPAIN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SPAIN; YOUNG ADULT;

EID: 79956220125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019819     Document Type: Article

References (38)

1. Gralnek IM, Barkun AN, Bardou M, (2008) Management of acute bleeding from a peptic ulcer. N Engl J Med 359: 928-37.
2. de Abajo FJ, Rodríguez LA, Montero D, (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319: 1106-9.
3. Dunn NR, Pearce GL, Shakir SA, (2000) Association between SSRIs and upper gastrointestinal bleeding SSRIs are no more likely than other drugs to cause such bleeding. BMJ 320: 1405-6.
4. van Walraven C, Mamdani MM, Wells PS, Williams JI, (2001) Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323: 655-8.
5. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, et al. (2003) Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 163: 59-64.
6. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, et al. (2004) Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 164: 2367-70.
7. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, et al. (2005) Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 22: 175-81.
8. Wessinger S, Kaplan M, Choi L, Williams M, Lau C, et al. (2006) Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23: 937-44.
9. Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R, (2007) Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 63: 403-8.
10. Vidal X, Ibáñez L, Vendrell L, Conforti A, Laporte JR, on behalf of the Sapnish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding (2008) Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants. A case-control study. Drug Safety 31: 159-68.
11. Lewis JD, Strom BL, Localio AR, Metz DC, Farrar JT, et al. (2008) Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf 17: 328-35.
12. de Abajo FJ, García-Rodríguez LA, (2008) Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 65: 795-803.
13. Opatrny L, Delaney JA, Suissa S, (2008) Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol 66: 76-81.
14. Barbui C, Andretta M, De Vitis G, Rossi E, D'Arienzo F, et al. (2009) Antidepressant drug prescription and risk of abnormal bleeding: a case-control study. J Clin Psychopharmacol 29: 33-8.
15. Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J, (2009) Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 104: 1475-82.
16. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J, (2009) An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 7: 1314-21.
17. Tatsumi M, Groshan K, Blakely RD, Richelson E, (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340: 249-58.
18. Brown H, Prescott R, (2006) Applied Mixed Models in Medicine, 2nd Edition New Jersey John Wiley and Sons pp. 320-1.
19. Bates D, Sarkar D, (2007) lme4: Linear Mixed-Effects Models Using S4 Classes. R package version 0.999375-26, URL http://CRAN.R-project.org/. Accessed 2011 Apr 25.
20. Pinheiro JC, Bates DM, (2006) Mixed-Effects Models in S and S-PLUS, 3rd Edition New-York Springer-Verlag.
21. Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, et al. (2002) A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol 29: 804-12.
22. Dickinson T, Malhi S, Painter S, Pyott J, Sawhney A, (2000) Association between SSRIs and upper gastrointestinal bleeding. Self treatment with non-steroidal drugs may be confounding factor. BMJ 320: 1406.
23. Rothman KJ, Greenland S, (1998) Modern Epidemiology 2nd Edition Philadelphia Lippincott-Raven pp. 100-2.
24. Movig KL, Janssen MW, de Waal Malefijt J, Kabel PJ, Leufkens HG, et al. (2003) Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med 163: 2354-8.
25. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S, (2000) Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 50: 43-7.
26. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, et al. (2002) Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 33: 1465-73.
27. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, et al. (2007) Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 38: 3049-51.
28. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC, (2008) Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 42: 177-84.
29. Salkeld E, Ferris LE, Juurlink DN, (2008) The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 28: 230-4.
30. Layton D, Clark DW, Pearce GL, Shakir SA, (2001) Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 57: 167-76.
31. Skop BP, Brown TM, (1996) Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37: 12-6.
32. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, et al. (2000) Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 68: 435-42.
33. McCloskey DJ, Postolache TT, Vittone BJ, Nghiem KL, Monsale JL, et al. (2008) Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl Res 151: 168-72.
34. Hougardy DM, Egberts TC, van der Graaf F, Brenninkmeijer VJ, Derijks LJ, (2008) Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br J Clin Pharmacol 65: 761-6.
35. Ahrens T, Frankhauser P, Lederbogen F, Deuschle M, (2007) Effect of single-dose sertraline on the hypothalamus-pituitaryadrenal system, autonomic nervous system, and platelet function. J Clin Psychopharmacol 27: 602-6.
36. Remaley AT, Kennedy JM, Laposata M, (1989) Evaluation of the clinical utility of platelet aggregation studies. Am J Hematol 31: 188-93.
37. Takeuchi K, Tanaka A, Takahira Y, Taniguchi M, (2005) Selective serotonin re-uptake inhibitors aggravate antral ulcers induced by indomethacin in rat stomachs. Gastroenterology 129: 1108.
38. Martín Arias LH, Treceño C, Ortega S, Velasco V, Carvajal A, et al. (2010) Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption. Pharmacoepidemiol Drug Saf 19: 895-900.